Trial intelligence / Profile preview

Continuous versus extended infusion of meropenem in pediatric sepsis

TCTR20260530009Phase 4Completed

Sponsor
Faculty of Pharmacy Universitas Indonesia
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of meropenem in sepsis, sponsored by Faculty of Pharmacy Universitas Indonesia. Started Dec 2024; status: completed.

02

Drugs

meropenem
03

Conditions

sepsis

Beyond the preview

Go deeper on TCTR20260530009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260530009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call